Vision impairment, blindness affect 66 percent of nursing home residents in study
By
Alicia Lasek
Nov 29, 2022
Vision impairment and blindness were linked to morbidity in a study across 74 facilities. But corrective lenses may play a big role in improving resident outcomes, researchers say.
FDA no longer requires positive COVID-19 test to prescribe Paxlovid, Lagevrio
By
Alicia Lasek
Feb 01, 2023
The FDA on Wednesday made it easier for clinicians to prescribe these antiviral drugs in cases where transmission is evident and the patient is at high risk of severe illness.
Amyloid brain plaques not a sure sign of Alzheimer’s, researchers find
By
Alicia Lasek
Jan 12, 2023
A new study challenges the theory that an increase in brain amyloid protein signals Alzheimer’s disease. The findings may be especially relevant to clinicians as amyloid-targeting drugs such as Leqembi...
Vascular risk factors raise odds of Alzheimer’s disease in Blacks, Hispanics: study
By
Alicia Lasek
Jan 05, 2023
Vascular risk helps to explain the outsized odds of Alzheimer’s faced by African Americans and Hispanics in the United States, a new study has found.
Increasing daily protein by 25g lowers hip fracture odds by 14 percent in study
By
Alicia Lasek
Nov 30, 2022
Women who increase their daily protein intake by 25 grams have a 14% lower risk of hip fracture, and underweight women may derive even more benefit, food scientists report.
Lack of knowledge on osteoporosis is widespread, may lead to undertreatment, investigators find
By
Alicia Lasek
Jun 08, 2023
Despite experiencing fractures attributable to osteoporosis, many women in a study had not undergone screening for the disease, researchers say.
COVID mortality trending older, with 9 in 10 deaths in adults aged 65 and older
By
Alicia Lasek
Nov 30, 2022
Overall, people aged 65 and older accounted for approximately 90% of US COVID-19 deaths in October, finds a new analysis of federal data.
Patient advocates decry CMS decision on Alzheimer’s drug coverage
By
Alicia Lasek
Feb 24, 2023
The Alzheimer’s Association and others have strongly criticized a decision by CMS to stand by its highly restrictive coverage for new dementia drugs.
WHO turns attention to fungal infections as drug resistance builds
By
Alicia Lasek
Oct 26, 2022
The World Health Organization has created a first-ever priority list of fungi that it says pose the greatest emerging threats to public health.
Medicare Advantage retaining sicker patients with more complex health needs: study
By
Alicia Lasek
Jun 29, 2023
After years of criticism for cherry-picking healthier people for enrollment, Medicare Advantage is now holding onto more patients with chronic conditions, investigators say.